Company intelligence / Profile preview

Huarong KingSung Biotechnology

Tianjin, Tianjin, China

Ownership: Private
Development stage: Other

Overview

Huarong KingSung Biotechnology is a high-tech medical company focused on developing innovative surgical solutions, particularly for microsurgery. The company has developed several advanced products using proprietary platforms in vascular anastomosis and biomaterials. Its degradable magnesium alloy product has entered clinical trials[1]. The group holds 145 patents and multiple original products have reached international advanced levels[2].

Therapeutic areas: CardiovascularOther
Modalities: DeviceBiologicPolymer material-based deviceMagnesium alloy-based device
Industry: Surgical Medical Devices

Partnerships

Collaborates with domestic/international universities, research institutions, and clinical experts for scientific research projects

Beyond the preview

Go deeper on Huarong KingSung Biotechnology.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Huarong KingSung Biotechnology.

Explore the full profile